IDH2 and B-cell chronic lymphocytic leukemia: Van Damme M et al[25] found the TET 1 and 3 and IDH2 levels are decreased in Chronic Lymphocytic Leukemia cells compared with those in healthy B cells, suggesting that epigenetic changes based on the TET/IDH function are potentially associated with disease progression.